d-MAPPS

BIOLOGICAL2 trials

Sponsors

Regenerative Ocular Immunobiologics LLC

Conditions

oGHVDoGVHD

Phase 1

Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Active, not recruitingNCT06852768

Regenerative Ocular Immunobiologics LLCoGHVD

Start: 2025-01-10End: 2026-12-01Target: 15Updated: 2026-07-08

Unknown Phase

Expanded Access for d-MAPPS™ Ophthalmic Solution, in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)

Regenerative Ocular Immunobiologics LLCoGVHD

Updated: 2025-10-10